中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (E)-3-(4-methoxyphenyl)pent-2-enedioic acid | 106833-44-7 | C12H12O5 | 236.224 |
—— | 3-(4-methoxyphenyl)-2,3-ene-pentanedioic acid | 66066-43-1 | C12H12O5 | 236.224 |
—— | 3-(4-methoxyphenyl)-2-pentenedioic acid | 66066-43-1 | C12H12O5 | 236.224 |
—— | (E)-3-(4-methoxyphenyl)but-2-enoic acid | 19169-94-9 | C11H12O3 | 192.214 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 5-acetyl-4-(4-methoxyphenyl)-5H-pyran-2,6-dione | 67074-99-1 | C14H12O5 | 260.246 |
Unsaturated spirocyclic lactams stemming from a variant of the three-component Castagnoli–Cushman reaction successfully underwent hydrogenation to enable access to fully saturated spirocyclic lactams. The subsequent lactam reduction gave rise to 2-spiro piperidine building blocks. The latter can be further elaborated in compound libraries and, on their own, show propensity to activate trace amine-associated receptor 1 (TAAR1), an important target for CNS disease.
源自三组分Castagnoli–Cushman反应变体的不饱和螺环内酰胺成功经过氢化反应,以便访问完全饱和的螺环内酰胺。随后的内酰胺还原产生了2-螺环哌啶构建块。后者可以在化合物库中进一步详细研究,并且本身显示出激活微量胺相关受体1(TAAR1)的倾向,这是中枢神经系统疾病的重要靶点。